Molecular diagnosis of von Willebrand disease
Authors:
- 20 February 2017
- journal article
- review article
- Published by Wiley in Haemophilia
- Vol. 23 (2) , 188-197
Abstract
The role of molecular characterization in the diagnosis of von Willebrand disease (VWD) is not essential if the patients have been extensively investigated using phenotypic analysis. On the other hand, if some of these phenotype assays are not available, the identification of the mutation causing the disease could be crucial for an accurate diagnosis. Nevertheless, there are several reasons for performing molecular analysis in patients phenotypically well characterized, e.g. to identify the mutation causing VWD can be useful for patients and their family members when prenatal diagnosis is required (type 3 or severe type 2). In this manuscript, we report the techniques used for the molecular characterization of suspected VWD patients. We describe the use of online von Willebrand factor database and online single nucleotide variation databases, the former to verify whether a candidate mutation has been previously identified in other VWD patients and the latter to ascertain whether a putative mutation has been reported earlier in healthy individuals. We listed the available in silico analysis tools, to determine the predicted pathogenicity of a sequence variant and to establish its possible negative effect on the normal splicing process. We also report the strategy that can be used to identify VWD type 2 patients' mutations in subjects who have been fully characterized using the phenotype assays.Keywords
Funding Information
- Alexion Pharmaceuticals
- Novo Nordisk
This publication has 39 references indexed in Scilit:
- High-throughput molecular diagnosis of von Willebrand disease by next generation sequencing methodsHaematologica, 2012
- First application of MLPA method in severe von Willebrand disease. Confirmation of a new largeVWFgene deletion and identification of heterozygous carriersBritish Journal of Haematology, 2010
- Genetic testing in von Willebrand disease: a rebuttalJournal of Thrombosis and Haemostasis, 2010
- Genetic testing for von Willebrand disease: the case againstJournal of Thrombosis and Haemostasis, 2010
- Genetic testing for von Willebrand disease: the case forJournal of Thrombosis and Haemostasis, 2010
- Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decayHaematologica, 2009
- The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort studyBlood, 2007
- Processing of von Willebrand Factor by ADAMTS-13Biochemistry, 2002
- Identification of disulfide-bridged substructures within human von Willebrand factorBiochemistry, 1987
- Pseudo-von Willebrand's DiseaseNew England Journal of Medicine, 1982